Literature DB >> 16705032

Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae.

Renuka Kadirvelraj1, Jorge Gonzalez-Outeiriño, B Lachele Foley, Meredith L Beckham, Harold J Jennings, Simon Foote, Michael G Ford, Robert J Woods.   

Abstract

Bacterial surface capsular polysaccharides (CPS) that are similar in carbohydrate sequence may differ markedly in immunogenicity and antigenicity. The structural origin of these phenomena is poorly understood. Such a case is presented by the Gram-positive bacteria Streptococcus agalactiae (Group B Streptococcus; GBS) type III (GBSIII) and Streptococcus pneumoniae (Pn) type 14 (Pn14), which share closely related CPS sequences. Nevertheless, antibodies (Abs) against GBSIII rarely cross-react with the CPS from Pn14. To establish the origin for the variation in CPS antigenicity, models for the immune complexes of CPS fragments from GBSIII and Pn14, with the variable fragment (Fv) of a GBS-specific mAb (mAb 1B1), are presented. The complexes are generated through a combination of comparative Ab modeling and automated ligand docking, followed by explicitly solvated 10-ns molecular dynamics simulations. The relationship between carbohydrate sequence and antigenicity is further quantified through the computation of interaction energies using the Molecular Mechanics-Generalized Born Surface Area (MM-GBSA) method, augmented by conformational entropy estimates. Despite the electrostatic differences between Pn14 and GBSIII CPS, analysis indicates that entropic penalties are primarily responsible for the loss of affinity of the highly flexible Pn14 CPS for mAb 1B1. The similarity of the solution conformation of the relatively rigid GBSIII CPS with that in the immune complex characterizes the previously undescribed 3D structure of the conformational epitope. The analysis provides a comprehensive interpretation for a large body of biochemical and immunological data related to Ab recognition of bacterial polysaccharides and should be applicable to other Ab-carbohydrate interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705032      PMCID: PMC1472444          DOI: 10.1073/pnas.0602815103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

Authors:  P A Kollman; I Massova; C Reyes; B Kuhn; S Huo; L Chong; M Lee; T Lee; Y Duan; W Wang; O Donini; P Cieplak; J Srinivasan; D A Case; T E Cheatham
Journal:  Acc Chem Res       Date:  2000-12       Impact factor: 22.384

2.  A graph-theory algorithm for rapid protein side-chain prediction.

Authors:  Adrian A Canutescu; Andrew A Shelenkov; Roland L Dunbrack
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

3.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

4.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Solvent interactions determine carbohydrate conformation.

Authors:  K N Kirschner; R J Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

6.  Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.

Authors:  Hilde-Kari Guttormsen; Carol J Baker; Moon H Nahm; Lawrence C Paoletti; Susu M Zughaier; Morven S Edwards; Dennis L Kasper
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Molecular dynamics simulations of galectin-1-oligosaccharide complexes reveal the molecular basis for ligand diversity.

Authors:  Michael G Ford; Thomas Weimar; Thies Köhli; Robert J Woods
Journal:  Proteins       Date:  2003-11-01

Review 8.  Pneumococcal vaccines: an update on current strategies.

Authors:  D Bogaert; P W M Hermans; P V Adrian; H C Rümke; R de Groot
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

9.  Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.

Authors:  M R Wessels; V Pozsgay; D L Kasper; H J Jennings
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

View more
  18 in total

1.  Thermodynamics and density of binding of a panel of antibodies to high-molecular-weight capsular polysaccharides.

Authors:  Shannon L Harris; Philip Fernsten
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

2.  Functional characterization of a ficolin-mediated complement pathway in amphioxus.

Authors:  Huiqing Huang; Shengfeng Huang; Yingcai Yu; Shaochun Yuan; Rui Li; Xin Wang; Hongchen Zhao; Yanhong Yu; Jun Li; Manyi Yang; Liqun Xu; Shangwu Chen; Anlong Xu
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

3.  The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.

Authors:  Dodi Safari; Huberta A T Dekker; Ger T Rijkers; Arie van der Ende; Johannis P Kamerling; Harm Snippe
Journal:  Glycoconj J       Date:  2011-10-08       Impact factor: 2.916

Review 4.  Molecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospects.

Authors:  Elisa Fadda; Robert J Woods
Journal:  Drug Discov Today       Date:  2010-06-08       Impact factor: 7.851

5.  Structural insights into the innate immune recognition specificities of L- and H-ficolins.

Authors:  Virginie Garlatti; Nicolas Belloy; Lydie Martin; Monique Lacroix; Misao Matsushita; Yuichi Endo; Teizo Fujita; Juan Carlos Fontecilla-Camps; Gérard J Arlaud; Nicole M Thielens; Christine Gaboriaud
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

6.  Molecular-level simulation of pandemic influenza glycoproteins.

Authors:  Rommie E Amaro; Wilfred W Li
Journal:  Methods Mol Biol       Date:  2012

7.  Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.

Authors:  Aaron F Carlin; Amanda L Lewis; Ajit Varki; Victor Nizet
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

8.  Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide.

Authors:  Filippo Carboni; Roberto Adamo; Monica Fabbrini; Riccardo De Ricco; Vittorio Cattaneo; Barbara Brogioni; Daniele Veggi; Vittoria Pinto; Irene Passalacqua; Davide Oldrini; Rino Rappuoli; Enrico Malito; Immaculada Y Ros Margarit; Francesco Berti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective.

Authors:  Dong Xu; E Irene Newhouse; Rommie E Amaro; Hsing C Pao; Lily S Cheng; Phineus R L Markwick; J Andrew McCammon; Wilfred W Li; Peter W Arzberger
Journal:  J Mol Biol       Date:  2009-02-05       Impact factor: 5.469

10.  Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective.

Authors:  E Irene Newhouse; Dong Xu; Phineus R L Markwick; Rommie E Amaro; Hsing C Pao; Kevin J Wu; Maqsudul Alam; J Andrew McCammon; Wilfred W Li
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.